Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Novo Nordisk AS, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Novo Nordisk AS, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Novo Nordisk AS, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Novo Nordisk AS, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Novo Nordisk AS, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Novo Nordisk AS, Medical Equipment, Deal Details 12
Venture Financing 12
Ra Pharma Raises USD58.5 Million in Series B Financing 12
Cianna Medical Raises USD4 Million in Venture Financing Round 14
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 15
Nevro Raises US$48 Million In Series C Financing 16
Ceterix Orthopaedics Raises US$19.5 Million In Series B Financing 18
Cianna Medical Secures US$12 Million In Series B Financing 19
Partnerships 20
Novo Nordisk Enters into Agreement with Glooko 20
Novo Nordisk Enters into Agreement with IBM Watson Health 21
Novo Nordisk Enters into Research Agreement with Massachusetts Institute of Technology 22
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 23
Novo Nordisk Enters Into Co-Development Agreement With Oxford University 24
Equity Offering 25
NNIT Prices IPO for USD191 Million 25
Novo Nordisk AS – Key Competitors 27
Novo Nordisk AS – Key Employees 28
Novo Nordisk AS – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 35
Strategy And Business Planning 35
Sep 29, 2016: Novo Nordisk announces plans to reduce workforce by approximately 1,000 employees 35
Aug 05, 2016: Caverion delivers a Large Project for Novo Nordisk’s new insulin production facility in Hillerod, Denmark 36
Financial Announcements 37
Nov 01, 2017: Novo Nordisk increased reported operating profit by 5% in the first nine months of 2017 37
Aug 09, 2017: Novo Nordisk increased reported operating profit by 8% in the first six months of 2017 38
May 03, 2017: Novo Nordisk increased reported operating profit by 10% in the first three months of 2017 39
Feb 02, 2017: Novo Nordisk increased adjusted operating profit by 6% in local currencies in 2016 40
Oct 28, 2016: Novo Nordisk increased adjusted operating profit by 7% in local currencies in the first nine months of 2016 41
Aug 05, 2016: Novo Nordisk increased adjusted operating profit by 8% in local currencies in the first six months of 2016 42
Apr 29, 2016: Novo Nordisk increased adjusted operating profit by 10% in local currencies in the first quarter of 2016 43
Feb 03, 2016: Novo Nordisk increased operating profit by 43% in 2015 to DKK 49.4 billion 44
Corporate Communications 45
Aug 15, 2017: Changes in Novo Nordisk Executive Management 45
May 16, 2017: Change in composition of the Board of Directors of Novo Nordisk 46
May 16, 2017: Change in composition of the Board of Directors of Novo Nordisk 47
Mar 01, 2017: Change in Novo Nordisk Executive Management 48
Sep 01, 2016: Lars Rebien Sorensen to retire as CEO of Novo Nordisk; Lars Fruergaard Jorgensen appointed as successor 49
Feb 12, 2016: Proposed changes in composition of the Board of Directors of Novo Nordisk 51
Other Significant Developments 52
Sep 26, 2017: Novo Nordisk Teams Up with HITLAB to Challenge Innovators to Develop Voice-Activated Technology for Diabetes Care with $75,000 in Prizes 52
Jul 12, 2017: Novo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management 53
Aug 05, 2016: Caverion delivers a Large Project for Novo Nordisk’s new insulin production facility in Hillerod, Denmark 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
Novo Nordisk AS, Medical Equipment, Key Facts, 2016 2
Novo Nordisk AS, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Novo Nordisk AS, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Novo Nordisk AS, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Novo Nordisk AS, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Novo Nordisk AS, Deals By Market, 2011 to YTD 2017 9
Novo Nordisk AS, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Ra Pharma Raises USD58.5 Million in Series B Financing 12
Cianna Medical Raises USD4 Million in Venture Financing Round 14
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 15
Nevro Raises US$48 Million In Series C Financing 16
Ceterix Orthopaedics Raises US$19.5 Million In Series B Financing 18
Cianna Medical Secures US$12 Million In Series B Financing 19
Novo Nordisk Enters into Agreement with Glooko 20
Novo Nordisk Enters into Agreement with IBM Watson Health 21
Novo Nordisk Enters into Research Agreement with Massachusetts Institute of Technology 22
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 23
Novo Nordisk Enters Into Co-Development Agreement With Oxford University 24
NNIT Prices IPO for USD191 Million 25
Novo Nordisk AS, Key Competitors 27
Novo Nordisk AS, Key Employees 28
Novo Nordisk AS, Subsidiaries 29